Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China
· Delayed Price · Currency is CNY 41.63
-0.80 (-1.89%)
Mar 9, 2026, 3:00 PM CST
SHA:600211 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 13,418 | 11,906 | 12,099 | 8,906 | 12,982 | 16,681 | Upgrade
|
| Market Cap Growth | 14.05% | -1.59% | 35.86% | -31.40% | -22.18% | 194.44% | Upgrade
|
| Enterprise Value | 11,504 | 9,880 | 10,369 | 7,662 | 12,467 | 16,027 | Upgrade
|
| Last Close Price | 41.63 | 35.29 | 34.33 | 24.38 | 35.22 | 44.78 | Upgrade
|
| PE Ratio | 13.69 | 11.33 | 15.11 | 24.08 | 62.13 | 39.90 | Upgrade
|
| Forward PE | - | 26.48 | 26.48 | 26.48 | 26.48 | 26.48 | Upgrade
|
| PS Ratio | 4.93 | 4.24 | 3.86 | 3.49 | 6.07 | 12.15 | Upgrade
|
| PB Ratio | 3.40 | 3.01 | 3.59 | 2.94 | 4.91 | 6.45 | Upgrade
|
| P/TBV Ratio | 4.26 | 3.20 | 3.86 | 3.44 | 5.88 | 10.27 | Upgrade
|
| P/FCF Ratio | 14.49 | 12.44 | 11.62 | 12.11 | - | 80.63 | Upgrade
|
| P/OCF Ratio | 13.97 | 11.97 | 11.38 | 10.64 | 35.42 | 38.96 | Upgrade
|
| EV/Sales Ratio | 4.23 | 3.52 | 3.31 | 3.00 | 5.83 | 11.67 | Upgrade
|
| EV/EBITDA Ratio | 13.02 | 10.21 | 9.37 | 10.12 | 19.06 | 33.05 | Upgrade
|
| EV/EBIT Ratio | 14.31 | 11.06 | 9.98 | 11.13 | 21.77 | 39.35 | Upgrade
|
| EV/FCF Ratio | 12.42 | 10.32 | 9.95 | 10.42 | - | 77.47 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.07 | 0.15 | 0.16 | 0.20 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 1.09 | 0.28 | 0.45 | 0.64 | 0.82 | 0.02 | Upgrade
|
| Debt / FCF Ratio | 1.05 | 0.29 | 0.48 | 0.66 | - | 0.05 | Upgrade
|
| Net Debt / Equity Ratio | -0.58 | -0.59 | -0.56 | -0.48 | -0.29 | -0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.61 | -2.43 | -1.69 | -1.91 | -1.17 | -1.59 | Upgrade
|
| Net Debt / FCF Ratio | -2.49 | -2.46 | -1.80 | -1.96 | 12.93 | -3.74 | Upgrade
|
| Asset Turnover | 0.52 | 0.60 | 0.72 | 0.65 | 0.63 | 0.48 | Upgrade
|
| Inventory Turnover | 1.17 | 1.32 | 1.50 | 1.73 | 2.17 | 2.69 | Upgrade
|
| Quick Ratio | 2.83 | 4.40 | 2.74 | 2.51 | 1.76 | 3.82 | Upgrade
|
| Current Ratio | 3.02 | 4.66 | 2.87 | 2.64 | 1.97 | 4.06 | Upgrade
|
| Return on Equity (ROE) | 25.98% | 28.86% | 25.30% | 13.23% | 8.14% | 16.71% | Upgrade
|
| Return on Assets (ROA) | 9.59% | 11.96% | 14.95% | 10.89% | 10.61% | 8.91% | Upgrade
|
| Return on Invested Capital (ROIC) | 42.03% | 52.87% | 60.70% | 32.15% | 25.90% | 21.17% | Upgrade
|
| Return on Capital Employed (ROCE) | 18.10% | 22.40% | 30.50% | 22.40% | 21.30% | 15.60% | Upgrade
|
| Earnings Yield | 7.31% | 8.83% | 6.62% | 4.15% | 1.61% | 2.51% | Upgrade
|
| FCF Yield | 6.90% | 8.04% | 8.61% | 8.26% | -0.46% | 1.24% | Upgrade
|
| Dividend Yield | 4.41% | 5.55% | 4.34% | 2.35% | 0.74% | 0.88% | Upgrade
|
| Payout Ratio | 60.75% | 47.03% | 61.74% | 26.55% | 63.41% | 45.16% | Upgrade
|
| Buyback Yield / Dilution | -0.13% | 0.14% | -0.09% | 0.21% | -0.53% | 0.98% | Upgrade
|
| Total Shareholder Return | 4.28% | 5.69% | 4.26% | 2.56% | 0.20% | 1.85% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.